Susceptibility and Diversity in the Therapy-Refractory Genus Scedosporium

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

(2014) A.M. Tortorano et al.   CLINICAL MICROBIOLOGY AND INFECTION

Proposed nomenclature for Pseudallescheria, Scedosporium and related genera

(2014) Michaela Lackner et al.   FUNGAL DIVERSITY

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients

(2013) A. Bernhardt et al.   Journal of Cystic Fibrosis

Nebulized voriconazole in infections with Scedosporium apiospermum — Case report and review of the literature

(2013) J. Holle et al.   Journal of Cystic Fibrosis

Taxonomy and epidemiology of Mucor irregularis , agent of chronic cutaneous mucormycosis

(2013) X.-L. Lu et al.   PERSOONIA

Scedosporium apiospermum EUMYCETOMA SUCCESSFULLY TREATED WITH ORAL VORICONAZOLE: REPORT OF A CASE AND REVIEW OF THE BRAZILIAN REPORTS ON SCEDOSPORIOSIS

(2013) Flávio de Mattos Oliveira et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species

(2012) Michaela Lackner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

(2012) Maiken Cavling Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hospital costs, length of stay and mortality attributable to invasive scedosporiosis in haematology patients

(2012) S.-C. Heng et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi

(2011) Josep Guarro   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates

(2011) M. Lackner et al.   MYCOSES

Parascedosporium and its relatives: phylogeny and ecological trends

(2011) Michaela Lackner' et al.   IMA Fungus

Experimental Murine Scedosporiosis: Histopathology and Azole Treatment

(2010) M. M. Rodriguez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Disseminated Scedosporium/Pseudallescheria Infection after Double-Lung Transplantation in Patients with Cystic Fibrosis

(2010) F. Morio et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Identification of Pseudallescheria and Scedosporium Species by Three Molecular Methods

(2010) Q. Lu et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical associations and prevalence ofScedosporiumspp. in Australian cystic fibrosis patients: identification of novel risk factors?

(2010) Christopher C. Blyth et al.   MEDICAL MYCOLOGY

Heterothallism inScedosporium apiospermumand description of its teleomorphPseudallescheria apiospermasp. nov.

(2010) Fèlix Gilgado et al.   MEDICAL MYCOLOGY

A review of GermanScedosporium prolificanscases from 1993 to 2007

(2009) K. Tintelnot et al.   MEDICAL MYCOLOGY

Host immune response againstScedosporiumspecies

(2009) Emmanuel Roilides et al.   MEDICAL MYCOLOGY

Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies

(2008) A. Espinel-Ingroff et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Scedosporium prolificans: an emerging pathogen in France?

(2008) Frederic Grenouillet et al.   MEDICAL MYCOLOGY

Ecology ofPseudallescheriaandScedosporiumspecies in human-dominated and natural environments and their distribution in clinical samples

(2008) J. Kaltseis et al.   MEDICAL MYCOLOGY